SlideShare a Scribd company logo
Protein Energy Malnutrition
(PEM),
Protein-Energy Wasting
(PEW)
Kidney Disease Wasting
(KDW),
Kidney Disease-Related PEM
By
Mabrouk Ramadan Al-Sheikh
Prof. of nephrology and Internal Medicine
Faculty of Medicine
Tanta University
”‫ي‬‫ك‬ ‫عند‬ ‫زينتكم‬ ‫خذوا‬ ‫آدم‬ ‫بني‬ ‫ا‬‫ل‬
‫وال‬ ‫واشربوا‬ ‫وكلوا‬ ‫مسجد‬
‫يحب‬ ‫ال‬ ‫إنه‬ ‫تسرفوا‬
‫المسرفين‬“
‫العظيم‬ ‫هللا‬ ‫صدق‬
(‫األعراف‬-31)
 Eat right to feel and live right
 Do not starve your patient
 Let the food be the medicine and not let the
medicine be the food. “Hippocrates”
‫نعيش‬ ‫ال‬ ،‫لنعيش‬ ‫نأكل‬ ‫نحن‬‫لنأكل‬
Agenda
 Definition
 Prevalence
 Factors contributing to malnutrition
 Nutritional assessment
 Nutritional therapy
 Conclusion and Recommendations
Agenda
 Definition
Prevalence
 Factors contributing to malnutrition
Nutritional assessment
 Nutritional therapy
 Conclusion and Recommendations
The International Society of Renal Nutrition
and Metabolism (ISRNM) expert panel
defined PEM (2012):
“state of decreased body stores of protein
and energy fuels i.e. body protein and fat
masses”
Definition
Definition
Component of PEM are
1. Clinical manifestations: unintentional poor
nutritional intake, unintentional BW loss,
depleted energy (fat tissues) stores, and loss
of somatic protein (low muscle mass).
2. Laboratory investigations: low level of
visceral protein; s. albumin, prealbumin and
transferrin and others.
3. Abnormal anthropometric measurements.
Readily utilizable criteria for the clinical diagnosis of PEM in CKD
Agenda
 Definition
Prevalence
 Factors contributing to malnutrition
Nutritional assessment
 Nutritional therapy
 Conclusion and Recommendations
Prevalence
Depending in part upon the method used and the
population studied, up to 40 to 70 % of patients with
end-stage renal disease are malnourished.
Agenda
 Definition
Prevalence
 Factors contributing to malnutrition
Nutritional assessment
 Nutritional therapy
 Conclusion and Recommendations
Potential causes of PEM in patients with non-dialysis
dependent CKD
Potential causes of PEM in patients with non-dialysis
dependent CKD
Factors contributing to malnutrition
Malnutrition can be secondary to :
1- Poor nutritional intake:
Overzealous dietary restrictions.
Delayed gastric emptying and diarrhea.
Intercurrent illness .
Hospitalization.
Other medical cormorbidities.
Factors contributing to malnutrition
Malnutrition can be secondary to :
1- Poor nutritional intake
Medication causing dyspepsia e.g. phos. binders, iron therapy .
Suppression of oral intake by PD load.
Inadequate dialysis
Decreased food intake on HD days
Monetary restriction
Depression
Altered taste sensation
2- Increased protein losses
Gastrointestinal blood loss:
“100ml blood = 14-17g protein.”
Intradialysis nitrogen loss:
“ HD : 6-8 g amino acid/ procedure”
“PD : 8-12 g protein/day”
Factors contributing to malnutrition
3- Increased protein catabolism
 Intercurrent illness and hospitalizations.
 Metabolic acidosis.
 Catabolism associated with HD
 Catabolic effects of hormones “cortisol,
PTH, glucagon”
Dysfunction of GH and IGF endocrine axis.
Factors contributing to malnutrition
Squeals of PEM
Malaise, fatigue, poor rehabilitation
Increase susceptibility to infection.
Impaired wound healing.
Increase hospitalization rate.
Increase morbidity and mortality rate.
Agenda
 Definition
Prevalence
 Factors contributing to malnutrition
 Nutritional assessment
 Nutritional therapy
 Conclusion and Recommendations
ASSESSMENT OF NUTRITIONAL STATUS
No single gold standard measurement.
Therefore, a panel of measurements is
recommended and including:
1. Assessment of dietary nutritional intake
2. Assessment of body composition.
3. Laboratory values
4. Scoring
ASSESSMENT OF NUTRITIONAL STATUS
No single gold standard measurement.
Therefore, a panel of measurements is
recommended and including:
1. Assessment of dietary nutritional intake
2. Assessment of body composition.
3. Laboratory values
4. Scoring
I-Nutritional Intake
A- Patient’s interview
• Often provides important clue to patients who
might be malnurished
• Symptoms: nausea, vomiting, anorexia, fatigue,
weight loss or gain
• Pharmacological therapy: steroid therapy, iron
therapy and phos. binder
• Co-morbidity and non uremic diseases e.g. DM,
alcoholism, GI diseases.
• Psychological issues.
I-Nutritional Intake
Physical Examination
 Should include anthropometry
The patient's actual BW is estimated and should be
compared to the recommended “dry or peer” body
weight.
The percentile change (if any) of the "dry weight"
should also be assessed approximately every month.
I-Nutritional Intake
B- Assessment of food intake
• Food questionnaire: the 24 h recall helps the patients to
remember food intake in the previous day and to
quantate it.
• Food record: quantitative and qualitative data on food
intake collected for an average 3 days including 2 two
week day and one week end day (3 days should include
dialysis and non-dialysis day).
• A food diary is very useful, especially if the patient
weighs the portions of food. The intake of protein, fat
and carbohydrate can then be calculated from standard
food tables.
I-Nutritional Intake
B- Assessment of food intake:
The semi-quantitative food–frequency questionnaire
(SFFQ): is used to assess the frequency of
consumption of food items and groups during a
specific reference time period, which may or may not
be the period the patient actually bases his(her)
recalls on.
I-Nutritional Intake
C-Protein equivalent of total nitrogen
appearance (PNA) & nPNA
Calculating the protein catabolic rate (PCR)
is a good indirect index for dietary
protein intake, expressed g/day.
KDOQI guidelines prefers the name:
protein equivalent of total nitrogen
appearance (PNA), expressed g/day.
Normalized nPNA ,expressed g/Kg/day.
I-Nutritional Intake
C-Protein equivalent of total nitrogen
appearance (PNA) & nPNA
 Determination of nPNA: Calculated by
Formula Computer Program
 Target level =1.0-1.2 g/Kg/day.
 Best survival rate at level= 1.0-1.4 g/Kg/day.
 An increased overall mortality rate at level
<0.8 or>1.4 g/Kg/day.
Interpretation of nPNA
Observation Interpretation Consideration
nPNA exceeds DPI
or is unexpectedly
high
Only tentative
conclusions about
protein intake possible
Catabolic state:
-Inadequate energy intake
-Presence of inflammation or inflammatory
stressors (fever, infection)
-Weight loss
- Metabolic acidosis
-Bioincompatible dialysis membrane.
Inaccurate diet record
Low lean body mass
nPNA less than
DPI or is
unexpectedly low
Only tentative
conclusions about
protein intake possible
Anabolic state:
-Corticosteroid use
- Recovery from infection or illness
- Pregnancy or growth
Inaccurate diet record
Edema or excess body weight
nPNA=DPI nPNA reflects protein
intake
Conclude patient is in nitrogen balance and
nPNA reflects intake if none of the above
apply
ASSESSMENT OF NUTRITIONAL STATUS
No single gold standard measurement.
Therefore, a panel of measurements is
recommended and including:
1. Assessment of dietary nutritional intake
2. Assessment of body composition.
3. Laboratory values
4. Scoring
II- Body composition
1- Body weight-based measures: BMI, weight for
height, edema-free BW, fat-free BW.
2- Skin and muscle anthropometry:
caliper, skin fold, extremity muscle mass.
3- Total body elements: total body potassium.
4- Energy-beam-based methods: total body N2,
DEXA, BIA, NIR.
5- Other method: underwater weighting.
A-BMI
The international classification of adult underweight, overweight and obesity
according to BMI
Classification BMI (kg/m2)
Underweight < 18.5
Severe thinness < 16
Moderate thinness 16-16.99
Mild thinness 17-18.49
Normal average 18.5-24.99
Overweight ≥ 25
Pre-obese 25-29.99
Obese ≥ 30
Obese class I 30-34.99
Obese class II 35-39.99
Obese class III ≥ 40
B-Anthropometry
Aim: to compare peer (ideal or average) BW to
the actual BW (special tables).
Anthropometry is practical, simple, rapid,
non-invasive, non-expensive and reproducible
technique for evaluating body fat and muscle
mass.
 It can be easily done by dietitian.
B-Anthropometry
K/DOQI guidelines :
The anthropometric measurement that are valid for
assessing nutritional status:
1. For body fat : triceps (or biceps) skin fold(TSF) .
2. For muscle mass : mid arm muscle circumference
(MAMC) &mid arm circumference (MAC).
3. For obesity : BMI
4. % of usual body weight (UBW) and % of standard
body weight (SBW).
This measures should be taken immediately post-dialysis
at right side of the body; best carried out by the same
observer
As a general rule, the percentile values/normal
limitation to the use of anthropometry is that serial
measurements are best carried out by the same
observer
adequate nutritionValues >95 %
risk of malnutritionvalues 75 % and 95 %
significant
malnutrition
values <75 %
More sophisticated measures of body composition
include :
Bioelectric impedance analysis (BIA)
Dual-energy x-ray absorptiometry (DEXA)
 A major drawback of these techniques is the
difficulty in distinguishing between fat mass and body
water.
 At present, anthropometry is the only
method that can be readily performed in most
units.
 BIA or DEXA should be reserved for selected
patients.
ASSESSMENT OF NUTRITIONAL STATUS
No single gold standard measurement.
Therefore, a panel of measurements is
recommended and including:
1. Assessment of dietary nutritional intake
2. Assessment of body composition.
3. Laboratory values
4. Scoring
III-Laboratory evaluation
1. Visceral protein: negative acute phase reactants;
albumin, prealbumin, transferrin and amino
acids.
2. Lipids: chlosterol, TG and other lipids.
3. Somatic protein and nitrogen surrogates: BUN
and serum creatinine.
4. Growth factors: IGF-1 and liptin.
5. Peripheral CBC, lymphocyts.
6. Others.
III-Laboratory evaluation
I-Plasma protein measurements
 Serum albumin
 Transferrin
 Prealbumin
 Amino acids
I-Plasma protein measurements
 Serum albumin
 Transferrin
 Prealbumin
 Amino acids
I-Plasma protein measurements
Serum Albumin
Clinical practice guidelines for nutrition were
published by a working group for the NKF/DOQI
recommended that the serum albumin
concentration (obtained either predialysis or
when stable) should be measured monthly.
I-Plasma protein measurements
Serum Albumin
Impact of Low serum albumin level:
 It is strong predictor of mortality and
hospitalization; risk rises dramatically and
logarithmically as levels decline below 4.0
g/dL.
 It has been shown to predict coronary
calcification.
I-Plasma protein measurements
Serum transferrin:
Serum transferrin is not good indicator of nutritional
status; perhaps due to fluctuations in iron stores,
presence of inflammation and changes in volume
status.
I-Plasma protein measurements
Prealbumin
The plasma concentration of prealbumin (has a
shorter half-life than albumin) provides a consistent
assessment of visceral protein and can be used to
assess the response to nutritional interventions
begun for presumed malnutrition as it.
 This protein is normally excreted and metabolized by
the kidney and tends to accumulate in renal failure.
I-Plasma protein measurements
Prealbumin
Value < 30 mg/dL is indicative of malnutrition in
the patients on maintenance hemodialysis.
I-Plasma protein measurements
Amino acids
 There is a variable plasma amino acid pattern
in ESRD.
In general, the levels of the essential and
branched chain AA are decreased, while the
nonessential AA are either within the normal
range or increased.
III-Laboratory evaluation
II-Plasma cholesterol concentration
 The plasma cholesterol concentration is reduced
in malnourished patients with normal renal
function.
 Cholesterol levels are also lower in patients with
ESRDs. In this setting, there is an inverse
relationship between mortality and the
cholesterol concentration.
III-Laboratory evaluation
III-Blood urea nitrogen
Reflects the balance between urea generation and
removal
 Malnourished patients often show a gradual reduction in
BUN and become wasted.
Low levels commonly seen in dialyzed patients (well
dialyzed or inadequately dialyzed) with poor nutrition.
Low predialysis BUN levels have also been associated
with increased mortality.
It is for this reason, protein catabolic rate is monitored in
dialysis patients, since this parameter can estimate
protein intake in the stable patient.
III-Laboratory evaluation
IV-Creatinine production
Since creatinine is produced from
nonenzymatic creatine metabolism in skeletal
muscle, estimating the rate of creatinine
production has been used to assess lean body
mass in stable patients.
Estimated lean body mass was below normal
in 47 and 66 % of hemodialysis and peritoneal
dialysis patients, a presumed reflection of
inadequate nutrition.
III-Laboratory evaluation
V- C-Reactive protein
 A positive acute phase reactant protein.
 It correlates negatively with visceral protein
concentration.
 Help to uncover potential covert
inflammation especially if serum level of
albumin or prealbumin is low.
ASSESSMENT OF NUTRITIONAL STATUS
No gold standard measurement.
Therefore, a panel of measurements is
recommended and including:
1. Assessment of dietary nutritional intake
2. Assessment of body composition.
3. Laboratory values
4. Scoring
Subjective global assessment (SGA)
• Conventional SGA is a simple method depends
on the experience of clinician to make an
overall evaluation of nutritional status.
• Advantages: includes objective data and
several manifestations of poor nutritional
status.
• Limitation: heavy reliance on the clinical
judgment and the inability to tailor a specific
nutritional therapy.
Subjective global assessment (SGA)
This is a clinical method for evaluation of
nutritional status; including:-
A- History and symptoms:
1- % of weight loss in the last 6 months
2- Dietary nutrient intake
3- Presence of anorexia, nausea, vomiting, diarrhea
or abdominal pain
4- Functional capacity
5- Metabolic demands in the view of activity
Subjective global assessment (SGA)
B-Physical parameters focus on:
• Assessment of subcutanous fat.
• Assessment of muscle wasting in the temporal
area, deltoid and quadriceps.
• Presence of sacral or ankle odema.
• Presence of ascites.
Subjective global assessment (SGA)
The SAG has good reproducibilty and correlates
well with outcome in ESRD.
Indices of malnutrition in HD patients
1. S. albumin concentration < 4.0 gm/dl.
2. Low s.prealbumin concentration (<30 mg/ dl)
3. Low b. urea & s. creatinine level in patients
with residual renal function.
4. PCR < 0.8gm/Kg/day.
5. Chol. concentration<150mg/dl(3.9mmol/L).
6. Transferrin <150 mg/dl.
Indices of malnutrition in HD patients
7. IGF-1 concentration < 300 µg/L.
8. Low predialysis serum K (and possibly
phosphororus) concentration.
9. Marked reduction in anthropometric
measurement
10. Continuous decline in estimated dry weight.
11. BW < 80% of ideal weight.
Agenda
• Definition
• Factors contributing to malnutrition
• Disorders of nutrient metabolism in CKD
• Nutritional assessment
• Nutritional therapy
• Conclusion and Recommendations
Nutritional therapy
Why malnutrition should be corrected?
 Many studies documented that poor
nutritional status increases the morbidity and
mortality CKD patients.
 Specifically; low s. creatinine ,albumin
concentration and % of ideal dry BW at time
of initiation of maintenance dialysis are
associated with increased risk of morbidity
and mortality during sub sequent years of HD.
Why malnutrition should be corrected?
PEM is one of the strongest predictors of
mortality and morbidity and is the third of the
killing triad in CKD and HD patients
1.CV accidents
2.Infection
3.PEM
Nutritional therapy
Interventions to prevent and/or treat malnutrition
in advanced kidney failure
CKD patients:
1- Close supervision and nutritional counseling (especially for patients on protein-
restricted diets).
2- Initiation of dialysis or kidney transplant in advanced CKD patients with
apparent uremic malnutrition despite vigorous attempts to rectify it.
Maintenance dialysis patients:
1- Appropriate amount of dietary protein (> 1.2 g/kg/day) and calorie (> 35
kcal/kg/day) intake.
2- Optimal dose of dialysis (urea reduction ratio > 70%).
Use of biocompatible hemodialysis membranes.
3-Nutritional support in chronic dialysis patients who are unable to meet their
dietary needs:
a-Oral supplements.
b-Tube feeds (if medically appropriate).
c-Intradialytic parenteral nutritional supplements for HD patients.
d-Amino acid dialysate for peritoneal dialysis patients.
e-TPN
Nutritional therapy
Strategies for correction of malnutrition
I. Dietary counseling, support and optimization.
II. Adequate dialysis.
III. Nutritional support in chronic HD patient who
are unable to meet their dietary needs:
1- Oral supplementation.
2- Tube feeding(if medically appropriate).
3- IDPN supplements for HD patients.
4- AA dialysate for PD patients.
5-Continuos total parenteral nutrition(TPN)
Nutritional therapy
Other interventions
1. Correction of anemia, metabolic acidosis and
SHPT.
2. Anabolic agents :insulin, growth factor, or
androgenic anabolic steroid.
3. Exercise.
4. Treatment of inflammation :statin, vit E.
5. Social work.
6. Pharmacy support.
7. Transplantation.
Nutritional therapy
Dietary requirement
The recommended average level of nutritional
intake are listed in the following table.
These recommendations are consistent with
NKF ,KDOQI and EBP guidelines for nutrition
for CKD patient.
Recommended intakes of protein, energy, and minerals
in kidney failure
Protein Energy Phosphorus Sodium
Chronic kidney disease
-Stages 1-3 (GFR > 30
ml/min)
-Stages 4-5 (GFR < 30
ml/min)
No restriction
0.60-0.75
g/kg/day
No restriction
35 kcal/kg/day
600-800 mg/day
600-800 mg/day
< 2 g/day
< 2 g/day
End-stage renal disease
-Hemodialysis
- Peritoneal dialysis
> 1.2 g/kg/day
> 1.3 g/kg/day
35 kcal/kg/day
35 kcal/kg/day
600-800 mg/day
600-800 mg/day
< 2 g/day
< 2 g/day
Acute renal failure
-No dialysis
- Dialysis
1-1.2 g/kg
IBW/day
1-1.2 g/kg
IBW/day
35 kcal/kg/day
35 kcal/kg/day
600-800 mg/day
600-800 mg/day
< 2 g/day
< 2 g/day
74
Recommended vitamin intake for patients
receiving maintenance hemodialysis
Thiamine (B1) 1.1–1.2 mg/day
Riboflavin (B2) 1.1–1.3 mg/day
Niacin 14–16 mg/day
Pantothenic Acid 5 mg/day
Vitamin B6 10 mg/day
Vitamin B12 2.4 mg/day
Biotin 30 mcg/day
Vitamin C 75–90 mg/day
Folic acid 1 mg/day
Zinc 15 mg/day
Nutritional therapy
Needs for individualization
Adherence to the renal diet is difficult & stressful.
Prescribed diet should be individualized to help every
patient in the terms of: cost, palatability,
comorbidities and cultural eating habits.
Too many restriction should be avoided as they may
lead to poor intake.
Reinforcement by all members of the family and
medical stuff.
Compliance should be assessed on regular basis even
monthly .
Strategies to enhance oral intake
Adequacy of dialysis
Early referral to dialysis is very crucial.
 Optimal dose of dialysis(URR>70%).
 Use of biocompatible HD membrane.
 Keep KT/V =1-1.2
 An important consensus:
Adequate dialysis coupled with good
nutrition is the main pillar for best quality of life.
Adequate dialysis corrects uremia & anorexia
which enhance nutrition.
Peer rather than actual BW
Protein and caloric recommendation should
be based on the peer BW for healthy subjects
of the same age, sex, height and body frame
size as the patients.
Agenda
 Definition
Prevalence
 Factors contributing to malnutrition
Nutritional assessment
 Nutritional therapy
 Conclusion and Recommendations
Recommendation
• Understanding and application of the nutritional
principles.
• Periodic assessment of nutritional status (once/
month) should be part of the routine care of CKD and
dialysis patients to permit early recognition.
• Providing and institution of appropriate therapy for
the best improvement of nutrition status .
• Renal dietitian should be a member of the medical
personals.
Take home message
• PEM is underappreciated, although it largely
preventable and completely curable.
Recommended intakes of protein, energy, and minerals
in kidney failure
Protein Energy Phosphorus Sodium
Chronic kidney disease
-Stages 1-3 (GFR > 30
ml/min)
-Stages 4-5 (GFR < 30
ml/min)
No restriction
0.60-0.75
g/kg/day
No restriction
35 kcal/kg/day
600-800 mg/day
600-800 mg/day
< 2 g/day
< 2 g/day
End-stage renal disease
-Hemodialysis
- Peritoneal dialysis
> 1.2 g/kg/day
> 1.3 g/kg/day
35 kcal/kg/day
35 kcal/kg/day
600-800 mg/day
600-800 mg/day
< 2 g/day
< 2 g/day
Acute renal failure
-No dialysis
- Dialysis
1-1.2 g/kg
IBW/day
1-1.2 g/kg
IBW/day
35 kcal/kg/day
35 kcal/kg/day
600-800 mg/day
600-800 mg/day
< 2 g/day
< 2 g/day
88
Recommended vitamin intake for patients
receiving maintenance hemodialysis
Thiamine (B1) 1.1–1.2 mg/day
Riboflavin (B2) 1.1–1.3 mg/day
Niacin 14–16 mg/day
Pantothenic Acid 5 mg/day
Vitamin B6 10 mg/day
Vitamin B12 2.4 mg/day
Biotin 30 mcg/day
Vitamin C 75–90 mg/day
Folic acid 1 mg/day
Zinc 15 mg/day
Recommended daily dietary intake for adult
patients on maintenance hemodialysis
Vitamins
EBPG nutrition, NDT 2007
A conceptual model for etiology of PEW in
CKD and direct clinical implications.
Response to reduced dietary protein and
energy intake.
Response to reduced dietary protein and
energy intake.
Response to reduced dietary protein and
energy intake.
• (A) Normal response. Reduced dietary protein and energy drive an
increase in hunger and
• a fall in REE, loss of protein preferentially from the visceral organs,
and increased insulin sensitivity of muscle.The liver and kidney
provide glucose, and serum albumin is maintained at a normal level.
• (B) Response with PEW. During PEW, the adaptations to increase
hunger and lower REE are blunted in part by an increased half-life of
leptin and ghrelin and in part by inflammation and dialysis. The loss
of protein occurs preferentially from muscle because of the effects of
metabolic acidosis, glucocorticoids, and inflammation, leading to
increased insulin resistance. Dialysis results in the loss of amino
acids, stimulating muscle protein breakdown. Under the influence of
inflammation and metabolic acidosis, the liver makes glutamine for
deamination in the kidney, increases acute-phase reactants, and
reduces serum albumin. The kidney increases glucose production
from glutamine under the influence of metabolic acidosis.
Potential causes of frailty and protein-energy wasting
in elderly patients with end stage kidney disease.
Clinical consequences of frailty and protein-energy
wasting in elderly patients with end stage kidney
disease.
Potential preventive and therapeutic strategies
for frailty and PEW in elderly ESRD patients
Readily utilizable criteria for the clinical diagnosis of protein
energy wasting in chronic kidney disease criteria
Selected nutritional parameters for varying
levels of kidney disease
Strategies to enhance oral intake
Potential causes of protein-energy wasting in patients
with non-dialysis dependent chronic kidney disease
Potential causes of PEM in patients with non-dialysis
dependent CKD
Potential causes of PEM in patients with non-dialysis
dependent CKD
Methods of evaluation for diagnosis of PEM in
patients with non-dialysis- dependent CKD
Schematic representation of the development of
protein-energy wasting with advancing stages of CKD
Selected nutritional parameters for varying
levels of kidney disease (K/DOQI guidelines)
Nutritional
Parameters
Stages 1-4 CKD Stage 5
Hemodialysis
Calories (kcal/kg/d) 30 – 35 35 - 60
Protein (g/kg/d) 0.6 – 0.75 1.2
Fat (% total kcal) For patients at risk for CVD, < 10%
saturated fat, 250-300 mg cholesterol/d
Sodium (g/d) < 2 2
Potassium (g/d) Match to laboratory
values
2 - 3
Calcium (g/d) 1.2 2 from diet and
medicines
Phosphorus (mg/d) Match to laboratory
values
800 – 1000
Fluid (ml/d) Unrestricted with
normal urine output
1000 + urine

More Related Content

What's hot

Diabetic Kidney Disease 2022 Update
Diabetic Kidney Disease 2022 UpdateDiabetic Kidney Disease 2022 Update
Diabetic Kidney Disease 2022 Update
Christos Argyropoulos
 
Diet in ckd
Diet in ckdDiet in ckd
MNT in chronic renal failure
MNT in chronic renal failureMNT in chronic renal failure
MNT in chronic renal failure
BALASUBRAMANIAM IYER
 
Diabetic nephropathy
Diabetic nephropathyDiabetic nephropathy
Diabetic nephropathy
Ankur Varshney
 
Nutrition of patients undergoing dialysis
Nutrition of patients undergoing dialysisNutrition of patients undergoing dialysis
Nutrition of patients undergoing dialysis
Maniz Joshi
 
Management of anemia in chronic kidney disease -
Management of anemia in chronic kidney disease -Management of anemia in chronic kidney disease -
Management of anemia in chronic kidney disease -
Boushra Alsaoor
 
Nutrition in renal patient
Nutrition in renal patientNutrition in renal patient
Nutrition in renal patient
FarragBahbah
 
Kidney Disease Case Study
Kidney Disease Case StudyKidney Disease Case Study
Kidney Disease Case Study
lusimartin
 
Medical nutrition therapy for Hemodialysis
Medical nutrition therapy for HemodialysisMedical nutrition therapy for Hemodialysis
Medical nutrition therapy for Hemodialysis
JakeBrandonAndal01
 
Hypokalemia (Practical Approach) - Dr. Gawad
Hypokalemia (Practical Approach) - Dr. GawadHypokalemia (Practical Approach) - Dr. Gawad
Hypokalemia (Practical Approach) - Dr. Gawad
NephroTube - Dr.Gawad
 
Diabetes Mellitus Management in CKD (Clinical Tips) - Dr. Gawad
Diabetes Mellitus Management in CKD (Clinical Tips) - Dr. GawadDiabetes Mellitus Management in CKD (Clinical Tips) - Dr. Gawad
Diabetes Mellitus Management in CKD (Clinical Tips) - Dr. Gawad
NephroTube - Dr.Gawad
 
Ckd
CkdCkd
Renal anemia
Renal anemiaRenal anemia
Nutrition Therapy For CKD: A Case Study Approach
Nutrition Therapy For CKD: A Case Study ApproachNutrition Therapy For CKD: A Case Study Approach
Nutrition Therapy For CKD: A Case Study Approach
kiolinski
 
Hyponatremia (Practical Approach) - Dr. Gawad
Hyponatremia (Practical Approach) - Dr. GawadHyponatremia (Practical Approach) - Dr. Gawad
Hyponatremia (Practical Approach) - Dr. Gawad
NephroTube - Dr.Gawad
 
Diabetic kidney disease
Diabetic kidney diseaseDiabetic kidney disease
Diabetic kidney disease
IPMS- KMU KPK PAKISTAN
 
Hypertension and renal diseases
Hypertension and renal diseasesHypertension and renal diseases
Hypertension and renal diseases
University of Florida
 
diabetic nephropathy
diabetic nephropathydiabetic nephropathy
diabetic nephropathy
nutritionistrepublic
 
Adequacy of Hemodialysis
Adequacy of HemodialysisAdequacy of Hemodialysis
Adequacy of Hemodialysis
MNDU net
 
Nutritional management of renal diseases
Nutritional management of renal diseasesNutritional management of renal diseases
Nutritional management of renal diseases
Wajid Rather
 

What's hot (20)

Diabetic Kidney Disease 2022 Update
Diabetic Kidney Disease 2022 UpdateDiabetic Kidney Disease 2022 Update
Diabetic Kidney Disease 2022 Update
 
Diet in ckd
Diet in ckdDiet in ckd
Diet in ckd
 
MNT in chronic renal failure
MNT in chronic renal failureMNT in chronic renal failure
MNT in chronic renal failure
 
Diabetic nephropathy
Diabetic nephropathyDiabetic nephropathy
Diabetic nephropathy
 
Nutrition of patients undergoing dialysis
Nutrition of patients undergoing dialysisNutrition of patients undergoing dialysis
Nutrition of patients undergoing dialysis
 
Management of anemia in chronic kidney disease -
Management of anemia in chronic kidney disease -Management of anemia in chronic kidney disease -
Management of anemia in chronic kidney disease -
 
Nutrition in renal patient
Nutrition in renal patientNutrition in renal patient
Nutrition in renal patient
 
Kidney Disease Case Study
Kidney Disease Case StudyKidney Disease Case Study
Kidney Disease Case Study
 
Medical nutrition therapy for Hemodialysis
Medical nutrition therapy for HemodialysisMedical nutrition therapy for Hemodialysis
Medical nutrition therapy for Hemodialysis
 
Hypokalemia (Practical Approach) - Dr. Gawad
Hypokalemia (Practical Approach) - Dr. GawadHypokalemia (Practical Approach) - Dr. Gawad
Hypokalemia (Practical Approach) - Dr. Gawad
 
Diabetes Mellitus Management in CKD (Clinical Tips) - Dr. Gawad
Diabetes Mellitus Management in CKD (Clinical Tips) - Dr. GawadDiabetes Mellitus Management in CKD (Clinical Tips) - Dr. Gawad
Diabetes Mellitus Management in CKD (Clinical Tips) - Dr. Gawad
 
Ckd
CkdCkd
Ckd
 
Renal anemia
Renal anemiaRenal anemia
Renal anemia
 
Nutrition Therapy For CKD: A Case Study Approach
Nutrition Therapy For CKD: A Case Study ApproachNutrition Therapy For CKD: A Case Study Approach
Nutrition Therapy For CKD: A Case Study Approach
 
Hyponatremia (Practical Approach) - Dr. Gawad
Hyponatremia (Practical Approach) - Dr. GawadHyponatremia (Practical Approach) - Dr. Gawad
Hyponatremia (Practical Approach) - Dr. Gawad
 
Diabetic kidney disease
Diabetic kidney diseaseDiabetic kidney disease
Diabetic kidney disease
 
Hypertension and renal diseases
Hypertension and renal diseasesHypertension and renal diseases
Hypertension and renal diseases
 
diabetic nephropathy
diabetic nephropathydiabetic nephropathy
diabetic nephropathy
 
Adequacy of Hemodialysis
Adequacy of HemodialysisAdequacy of Hemodialysis
Adequacy of Hemodialysis
 
Nutritional management of renal diseases
Nutritional management of renal diseasesNutritional management of renal diseases
Nutritional management of renal diseases
 

Similar to Protein energy malnutrition in CKD

Nutritional assessment
Nutritional assessmentNutritional assessment
Nutritional assessment
Ahmed Abudeif
 
Nutrition in surgical patients
Nutrition in surgical patientsNutrition in surgical patients
Nutrition in surgical patients
AjayKumar4497
 
1_Nutrition_in_critical_care_dr_Daniel_Maranata.pdf
1_Nutrition_in_critical_care_dr_Daniel_Maranata.pdf1_Nutrition_in_critical_care_dr_Daniel_Maranata.pdf
1_Nutrition_in_critical_care_dr_Daniel_Maranata.pdf
wisnukuncoro11
 
Nutrition in Chronic Respiratory Diseases.ppt
Nutrition in Chronic Respiratory Diseases.pptNutrition in Chronic Respiratory Diseases.ppt
Nutrition in Chronic Respiratory Diseases.ppt
Dr Riham Hazem Raafat
 
nutrition_in_hemodialysis.pptx
nutrition_in_hemodialysis.pptxnutrition_in_hemodialysis.pptx
nutrition_in_hemodialysis.pptx
omniahamad4
 
Perioperative nutrition support
Perioperative nutrition supportPerioperative nutrition support
Perioperative nutrition support
Mario Sanchez
 
Nutrirtion 2015
Nutrirtion 2015Nutrirtion 2015
Nutrirtion 2015
omerhashmi88
 
Daily minimum nutritional requirements of the critically ill
Daily minimum nutritional requirements of the critically illDaily minimum nutritional requirements of the critically ill
Daily minimum nutritional requirements of the critically ill
RalekeOkoye
 
Importance of nutritional management during hospitalization
Importance of nutritional management during hospitalizationImportance of nutritional management during hospitalization
Importance of nutritional management during hospitalization
Bushra Tariq
 
Themanagementofobesity 100312193454 Phpapp02
Themanagementofobesity 100312193454 Phpapp02Themanagementofobesity 100312193454 Phpapp02
Themanagementofobesity 100312193454 Phpapp02
Saurabh
 
The Management Of Obesity
The Management Of ObesityThe Management Of Obesity
The Management Of Obesity
MD Specialclass
 
The Management Of Obesity
The Management Of ObesityThe Management Of Obesity
The Management Of Obesity
MD Specialclass
 
Themanagementofobesity 100312193454 Phpapp02
Themanagementofobesity 100312193454 Phpapp02Themanagementofobesity 100312193454 Phpapp02
Themanagementofobesity 100312193454 Phpapp02
MD Specialclass
 
Protien Energy Malnutrition and Obesity.pdf
Protien Energy Malnutrition and Obesity.pdfProtien Energy Malnutrition and Obesity.pdf
Protien Energy Malnutrition and Obesity.pdf
RahulKishor4
 
U_of_Kansaffffffffs_ACOVE_Malnutrition.ppt
U_of_Kansaffffffffs_ACOVE_Malnutrition.pptU_of_Kansaffffffffs_ACOVE_Malnutrition.ppt
U_of_Kansaffffffffs_ACOVE_Malnutrition.ppt
MiroMohamed2
 
Principles of Diet Therapy and Therapeutic Nutrition
Principles of Diet Therapy  and Therapeutic NutritionPrinciples of Diet Therapy  and Therapeutic Nutrition
Principles of Diet Therapy and Therapeutic Nutrition
Biotech Online
 
Nutrition management
Nutrition managementNutrition management
Nutrition management
Surgeon Ibrahim
 
Nutrition guidelines
Nutrition guidelinesNutrition guidelines
Nutrition guidelines
Mayur Ganvir
 
Nutrition therapy work shop dawly first part 2017
Nutrition therapy work shop dawly   first part  2017Nutrition therapy work shop dawly   first part  2017
Nutrition therapy work shop dawly first part 2017
FarragBahbah
 
Basic Intravenous Therapy 4: Total Parenteral Nutrition
Basic Intravenous Therapy 4: Total Parenteral NutritionBasic Intravenous Therapy 4: Total Parenteral Nutrition
Basic Intravenous Therapy 4: Total Parenteral Nutrition
Ronald Magbitang
 

Similar to Protein energy malnutrition in CKD (20)

Nutritional assessment
Nutritional assessmentNutritional assessment
Nutritional assessment
 
Nutrition in surgical patients
Nutrition in surgical patientsNutrition in surgical patients
Nutrition in surgical patients
 
1_Nutrition_in_critical_care_dr_Daniel_Maranata.pdf
1_Nutrition_in_critical_care_dr_Daniel_Maranata.pdf1_Nutrition_in_critical_care_dr_Daniel_Maranata.pdf
1_Nutrition_in_critical_care_dr_Daniel_Maranata.pdf
 
Nutrition in Chronic Respiratory Diseases.ppt
Nutrition in Chronic Respiratory Diseases.pptNutrition in Chronic Respiratory Diseases.ppt
Nutrition in Chronic Respiratory Diseases.ppt
 
nutrition_in_hemodialysis.pptx
nutrition_in_hemodialysis.pptxnutrition_in_hemodialysis.pptx
nutrition_in_hemodialysis.pptx
 
Perioperative nutrition support
Perioperative nutrition supportPerioperative nutrition support
Perioperative nutrition support
 
Nutrirtion 2015
Nutrirtion 2015Nutrirtion 2015
Nutrirtion 2015
 
Daily minimum nutritional requirements of the critically ill
Daily minimum nutritional requirements of the critically illDaily minimum nutritional requirements of the critically ill
Daily minimum nutritional requirements of the critically ill
 
Importance of nutritional management during hospitalization
Importance of nutritional management during hospitalizationImportance of nutritional management during hospitalization
Importance of nutritional management during hospitalization
 
Themanagementofobesity 100312193454 Phpapp02
Themanagementofobesity 100312193454 Phpapp02Themanagementofobesity 100312193454 Phpapp02
Themanagementofobesity 100312193454 Phpapp02
 
The Management Of Obesity
The Management Of ObesityThe Management Of Obesity
The Management Of Obesity
 
The Management Of Obesity
The Management Of ObesityThe Management Of Obesity
The Management Of Obesity
 
Themanagementofobesity 100312193454 Phpapp02
Themanagementofobesity 100312193454 Phpapp02Themanagementofobesity 100312193454 Phpapp02
Themanagementofobesity 100312193454 Phpapp02
 
Protien Energy Malnutrition and Obesity.pdf
Protien Energy Malnutrition and Obesity.pdfProtien Energy Malnutrition and Obesity.pdf
Protien Energy Malnutrition and Obesity.pdf
 
U_of_Kansaffffffffs_ACOVE_Malnutrition.ppt
U_of_Kansaffffffffs_ACOVE_Malnutrition.pptU_of_Kansaffffffffs_ACOVE_Malnutrition.ppt
U_of_Kansaffffffffs_ACOVE_Malnutrition.ppt
 
Principles of Diet Therapy and Therapeutic Nutrition
Principles of Diet Therapy  and Therapeutic NutritionPrinciples of Diet Therapy  and Therapeutic Nutrition
Principles of Diet Therapy and Therapeutic Nutrition
 
Nutrition management
Nutrition managementNutrition management
Nutrition management
 
Nutrition guidelines
Nutrition guidelinesNutrition guidelines
Nutrition guidelines
 
Nutrition therapy work shop dawly first part 2017
Nutrition therapy work shop dawly   first part  2017Nutrition therapy work shop dawly   first part  2017
Nutrition therapy work shop dawly first part 2017
 
Basic Intravenous Therapy 4: Total Parenteral Nutrition
Basic Intravenous Therapy 4: Total Parenteral NutritionBasic Intravenous Therapy 4: Total Parenteral Nutrition
Basic Intravenous Therapy 4: Total Parenteral Nutrition
 

More from أحمد عبد الوهاب الجندي

Immune nephritis
Immune nephritisImmune nephritis
Mg cvs calcific
Mg  cvs calcificMg  cvs calcific
Uric a &amp; kidney
Uric a &amp; kidneyUric a &amp; kidney
Asymptomatic hyperuricemia: Treat or Not
Asymptomatic hyperuricemia: Treat or NotAsymptomatic hyperuricemia: Treat or Not
Asymptomatic hyperuricemia: Treat or Not
أحمد عبد الوهاب الجندي
 
Dialytic support for AKI
Dialytic support for AKIDialytic support for AKI
Dialytic support for AKI
Dialytic support for AKIDialytic support for AKI
Donor assessment
Donor assessmentDonor assessment
Vasculopathy and ckd
Vasculopathy and ckdVasculopathy and ckd
CKD-MBD:Messages from clinical trials
CKD-MBD:Messages from clinical trialsCKD-MBD:Messages from clinical trials
CKD-MBD:Messages from clinical trials
أحمد عبد الوهاب الجندي
 
Dys glycemia in ckd 26 8-2015
Dys glycemia in ckd 26 8-2015Dys glycemia in ckd 26 8-2015
Dys glycemia in ckd 26 8-2015
أحمد عبد الوهاب الجندي
 
Diabetic nephropathy, patho physiology update
Diabetic nephropathy, patho physiology updateDiabetic nephropathy, patho physiology update
Diabetic nephropathy, patho physiology update
أحمد عبد الوهاب الجندي
 
Aki in icu
Aki in icuAki in icu
Aki in icu
Aki in icuAki in icu
Complications of hemodialysis
Complications of hemodialysisComplications of hemodialysis
Complications of hemodialysis
أحمد عبد الوهاب الجندي
 
Hemodialysis basics
Hemodialysis basicsHemodialysis basics
Pulm. renal syndromes(renal prespective)
Pulm. renal syndromes(renal prespective)Pulm. renal syndromes(renal prespective)
Pulm. renal syndromes(renal prespective)
أحمد عبد الوهاب الجندي
 
Pearls and myths in sle
Pearls and myths in slePearls and myths in sle
Uremic toxins
Uremic toxinsUremic toxins
To dialyse or not
To dialyse or notTo dialyse or not
Kidney and endocrine
Kidney and endocrineKidney and endocrine

More from أحمد عبد الوهاب الجندي (20)

Immune nephritis
Immune nephritisImmune nephritis
Immune nephritis
 
Mg cvs calcific
Mg  cvs calcificMg  cvs calcific
Mg cvs calcific
 
Uric a &amp; kidney
Uric a &amp; kidneyUric a &amp; kidney
Uric a &amp; kidney
 
Asymptomatic hyperuricemia: Treat or Not
Asymptomatic hyperuricemia: Treat or NotAsymptomatic hyperuricemia: Treat or Not
Asymptomatic hyperuricemia: Treat or Not
 
Dialytic support for AKI
Dialytic support for AKIDialytic support for AKI
Dialytic support for AKI
 
Dialytic support for AKI
Dialytic support for AKIDialytic support for AKI
Dialytic support for AKI
 
Donor assessment
Donor assessmentDonor assessment
Donor assessment
 
Vasculopathy and ckd
Vasculopathy and ckdVasculopathy and ckd
Vasculopathy and ckd
 
CKD-MBD:Messages from clinical trials
CKD-MBD:Messages from clinical trialsCKD-MBD:Messages from clinical trials
CKD-MBD:Messages from clinical trials
 
Dys glycemia in ckd 26 8-2015
Dys glycemia in ckd 26 8-2015Dys glycemia in ckd 26 8-2015
Dys glycemia in ckd 26 8-2015
 
Diabetic nephropathy, patho physiology update
Diabetic nephropathy, patho physiology updateDiabetic nephropathy, patho physiology update
Diabetic nephropathy, patho physiology update
 
Aki in icu
Aki in icuAki in icu
Aki in icu
 
Aki in icu
Aki in icuAki in icu
Aki in icu
 
Complications of hemodialysis
Complications of hemodialysisComplications of hemodialysis
Complications of hemodialysis
 
Hemodialysis basics
Hemodialysis basicsHemodialysis basics
Hemodialysis basics
 
Pulm. renal syndromes(renal prespective)
Pulm. renal syndromes(renal prespective)Pulm. renal syndromes(renal prespective)
Pulm. renal syndromes(renal prespective)
 
Pearls and myths in sle
Pearls and myths in slePearls and myths in sle
Pearls and myths in sle
 
Uremic toxins
Uremic toxinsUremic toxins
Uremic toxins
 
To dialyse or not
To dialyse or notTo dialyse or not
To dialyse or not
 
Kidney and endocrine
Kidney and endocrineKidney and endocrine
Kidney and endocrine
 

Recently uploaded

Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
shivalingatalekar1
 
ABDOMINAL TRAUMA in pediatrics part one.
ABDOMINAL TRAUMA in pediatrics part one.ABDOMINAL TRAUMA in pediatrics part one.
ABDOMINAL TRAUMA in pediatrics part one.
drhasanrajab
 
Light House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat EuropeLight House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat Europe
Lighthouse Retreat
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
Dr. Jyothirmai Paindla
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Oleg Kshivets
 
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradeshBasavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Dr. Madduru Muni Haritha
 
A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
Dr. Jyothirmai Paindla
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
rishi2789
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
Earlene McNair
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
Anurag Sharma
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
FFragrant
 
Management of Traumatic Splenic injury.pptx
Management of Traumatic Splenic injury.pptxManagement of Traumatic Splenic injury.pptx
Management of Traumatic Splenic injury.pptx
AkshaySarraf1
 
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptxThyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
chandankumarsmartiso
 
THERAPEUTIC ANTISENSE MOLECULES .pptx
THERAPEUTIC ANTISENSE MOLECULES    .pptxTHERAPEUTIC ANTISENSE MOLECULES    .pptx
THERAPEUTIC ANTISENSE MOLECULES .pptx
70KRISHPATEL
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Prof. Marcus Renato de Carvalho
 
Top Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in IndiaTop Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in India
SwisschemDerma
 

Recently uploaded (20)

Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
 
ABDOMINAL TRAUMA in pediatrics part one.
ABDOMINAL TRAUMA in pediatrics part one.ABDOMINAL TRAUMA in pediatrics part one.
ABDOMINAL TRAUMA in pediatrics part one.
 
Light House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat EuropeLight House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat Europe
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
 
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradeshBasavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
 
A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
 
Management of Traumatic Splenic injury.pptx
Management of Traumatic Splenic injury.pptxManagement of Traumatic Splenic injury.pptx
Management of Traumatic Splenic injury.pptx
 
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptxThyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
 
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
 
THERAPEUTIC ANTISENSE MOLECULES .pptx
THERAPEUTIC ANTISENSE MOLECULES    .pptxTHERAPEUTIC ANTISENSE MOLECULES    .pptx
THERAPEUTIC ANTISENSE MOLECULES .pptx
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
 
Top Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in IndiaTop Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in India
 

Protein energy malnutrition in CKD

  • 1.
  • 2. Protein Energy Malnutrition (PEM), Protein-Energy Wasting (PEW) Kidney Disease Wasting (KDW), Kidney Disease-Related PEM By Mabrouk Ramadan Al-Sheikh Prof. of nephrology and Internal Medicine Faculty of Medicine Tanta University
  • 3. ”‫ي‬‫ك‬ ‫عند‬ ‫زينتكم‬ ‫خذوا‬ ‫آدم‬ ‫بني‬ ‫ا‬‫ل‬ ‫وال‬ ‫واشربوا‬ ‫وكلوا‬ ‫مسجد‬ ‫يحب‬ ‫ال‬ ‫إنه‬ ‫تسرفوا‬ ‫المسرفين‬“ ‫العظيم‬ ‫هللا‬ ‫صدق‬ (‫األعراف‬-31)
  • 4.  Eat right to feel and live right  Do not starve your patient  Let the food be the medicine and not let the medicine be the food. “Hippocrates” ‫نعيش‬ ‫ال‬ ،‫لنعيش‬ ‫نأكل‬ ‫نحن‬‫لنأكل‬
  • 5. Agenda  Definition  Prevalence  Factors contributing to malnutrition  Nutritional assessment  Nutritional therapy  Conclusion and Recommendations
  • 6. Agenda  Definition Prevalence  Factors contributing to malnutrition Nutritional assessment  Nutritional therapy  Conclusion and Recommendations
  • 7. The International Society of Renal Nutrition and Metabolism (ISRNM) expert panel defined PEM (2012): “state of decreased body stores of protein and energy fuels i.e. body protein and fat masses” Definition
  • 8. Definition Component of PEM are 1. Clinical manifestations: unintentional poor nutritional intake, unintentional BW loss, depleted energy (fat tissues) stores, and loss of somatic protein (low muscle mass). 2. Laboratory investigations: low level of visceral protein; s. albumin, prealbumin and transferrin and others. 3. Abnormal anthropometric measurements.
  • 9. Readily utilizable criteria for the clinical diagnosis of PEM in CKD
  • 10. Agenda  Definition Prevalence  Factors contributing to malnutrition Nutritional assessment  Nutritional therapy  Conclusion and Recommendations
  • 11. Prevalence Depending in part upon the method used and the population studied, up to 40 to 70 % of patients with end-stage renal disease are malnourished.
  • 12.
  • 13.
  • 14. Agenda  Definition Prevalence  Factors contributing to malnutrition Nutritional assessment  Nutritional therapy  Conclusion and Recommendations
  • 15. Potential causes of PEM in patients with non-dialysis dependent CKD
  • 16. Potential causes of PEM in patients with non-dialysis dependent CKD
  • 17. Factors contributing to malnutrition Malnutrition can be secondary to : 1- Poor nutritional intake: Overzealous dietary restrictions. Delayed gastric emptying and diarrhea. Intercurrent illness . Hospitalization. Other medical cormorbidities.
  • 18. Factors contributing to malnutrition Malnutrition can be secondary to : 1- Poor nutritional intake Medication causing dyspepsia e.g. phos. binders, iron therapy . Suppression of oral intake by PD load. Inadequate dialysis Decreased food intake on HD days Monetary restriction Depression Altered taste sensation
  • 19. 2- Increased protein losses Gastrointestinal blood loss: “100ml blood = 14-17g protein.” Intradialysis nitrogen loss: “ HD : 6-8 g amino acid/ procedure” “PD : 8-12 g protein/day” Factors contributing to malnutrition
  • 20. 3- Increased protein catabolism  Intercurrent illness and hospitalizations.  Metabolic acidosis.  Catabolism associated with HD  Catabolic effects of hormones “cortisol, PTH, glucagon” Dysfunction of GH and IGF endocrine axis. Factors contributing to malnutrition
  • 21. Squeals of PEM Malaise, fatigue, poor rehabilitation Increase susceptibility to infection. Impaired wound healing. Increase hospitalization rate. Increase morbidity and mortality rate.
  • 22. Agenda  Definition Prevalence  Factors contributing to malnutrition  Nutritional assessment  Nutritional therapy  Conclusion and Recommendations
  • 23. ASSESSMENT OF NUTRITIONAL STATUS No single gold standard measurement. Therefore, a panel of measurements is recommended and including: 1. Assessment of dietary nutritional intake 2. Assessment of body composition. 3. Laboratory values 4. Scoring
  • 24.
  • 25. ASSESSMENT OF NUTRITIONAL STATUS No single gold standard measurement. Therefore, a panel of measurements is recommended and including: 1. Assessment of dietary nutritional intake 2. Assessment of body composition. 3. Laboratory values 4. Scoring
  • 26. I-Nutritional Intake A- Patient’s interview • Often provides important clue to patients who might be malnurished • Symptoms: nausea, vomiting, anorexia, fatigue, weight loss or gain • Pharmacological therapy: steroid therapy, iron therapy and phos. binder • Co-morbidity and non uremic diseases e.g. DM, alcoholism, GI diseases. • Psychological issues.
  • 27. I-Nutritional Intake Physical Examination  Should include anthropometry The patient's actual BW is estimated and should be compared to the recommended “dry or peer” body weight. The percentile change (if any) of the "dry weight" should also be assessed approximately every month.
  • 28. I-Nutritional Intake B- Assessment of food intake • Food questionnaire: the 24 h recall helps the patients to remember food intake in the previous day and to quantate it. • Food record: quantitative and qualitative data on food intake collected for an average 3 days including 2 two week day and one week end day (3 days should include dialysis and non-dialysis day). • A food diary is very useful, especially if the patient weighs the portions of food. The intake of protein, fat and carbohydrate can then be calculated from standard food tables.
  • 29. I-Nutritional Intake B- Assessment of food intake: The semi-quantitative food–frequency questionnaire (SFFQ): is used to assess the frequency of consumption of food items and groups during a specific reference time period, which may or may not be the period the patient actually bases his(her) recalls on.
  • 30. I-Nutritional Intake C-Protein equivalent of total nitrogen appearance (PNA) & nPNA Calculating the protein catabolic rate (PCR) is a good indirect index for dietary protein intake, expressed g/day. KDOQI guidelines prefers the name: protein equivalent of total nitrogen appearance (PNA), expressed g/day. Normalized nPNA ,expressed g/Kg/day.
  • 31. I-Nutritional Intake C-Protein equivalent of total nitrogen appearance (PNA) & nPNA  Determination of nPNA: Calculated by Formula Computer Program  Target level =1.0-1.2 g/Kg/day.  Best survival rate at level= 1.0-1.4 g/Kg/day.  An increased overall mortality rate at level <0.8 or>1.4 g/Kg/day.
  • 32. Interpretation of nPNA Observation Interpretation Consideration nPNA exceeds DPI or is unexpectedly high Only tentative conclusions about protein intake possible Catabolic state: -Inadequate energy intake -Presence of inflammation or inflammatory stressors (fever, infection) -Weight loss - Metabolic acidosis -Bioincompatible dialysis membrane. Inaccurate diet record Low lean body mass nPNA less than DPI or is unexpectedly low Only tentative conclusions about protein intake possible Anabolic state: -Corticosteroid use - Recovery from infection or illness - Pregnancy or growth Inaccurate diet record Edema or excess body weight nPNA=DPI nPNA reflects protein intake Conclude patient is in nitrogen balance and nPNA reflects intake if none of the above apply
  • 33. ASSESSMENT OF NUTRITIONAL STATUS No single gold standard measurement. Therefore, a panel of measurements is recommended and including: 1. Assessment of dietary nutritional intake 2. Assessment of body composition. 3. Laboratory values 4. Scoring
  • 34. II- Body composition 1- Body weight-based measures: BMI, weight for height, edema-free BW, fat-free BW. 2- Skin and muscle anthropometry: caliper, skin fold, extremity muscle mass. 3- Total body elements: total body potassium. 4- Energy-beam-based methods: total body N2, DEXA, BIA, NIR. 5- Other method: underwater weighting.
  • 35. A-BMI The international classification of adult underweight, overweight and obesity according to BMI Classification BMI (kg/m2) Underweight < 18.5 Severe thinness < 16 Moderate thinness 16-16.99 Mild thinness 17-18.49 Normal average 18.5-24.99 Overweight ≥ 25 Pre-obese 25-29.99 Obese ≥ 30 Obese class I 30-34.99 Obese class II 35-39.99 Obese class III ≥ 40
  • 36. B-Anthropometry Aim: to compare peer (ideal or average) BW to the actual BW (special tables). Anthropometry is practical, simple, rapid, non-invasive, non-expensive and reproducible technique for evaluating body fat and muscle mass.  It can be easily done by dietitian.
  • 37. B-Anthropometry K/DOQI guidelines : The anthropometric measurement that are valid for assessing nutritional status: 1. For body fat : triceps (or biceps) skin fold(TSF) . 2. For muscle mass : mid arm muscle circumference (MAMC) &mid arm circumference (MAC). 3. For obesity : BMI 4. % of usual body weight (UBW) and % of standard body weight (SBW). This measures should be taken immediately post-dialysis at right side of the body; best carried out by the same observer
  • 38. As a general rule, the percentile values/normal limitation to the use of anthropometry is that serial measurements are best carried out by the same observer adequate nutritionValues >95 % risk of malnutritionvalues 75 % and 95 % significant malnutrition values <75 %
  • 39. More sophisticated measures of body composition include : Bioelectric impedance analysis (BIA) Dual-energy x-ray absorptiometry (DEXA)  A major drawback of these techniques is the difficulty in distinguishing between fat mass and body water.
  • 40.  At present, anthropometry is the only method that can be readily performed in most units.  BIA or DEXA should be reserved for selected patients.
  • 41. ASSESSMENT OF NUTRITIONAL STATUS No single gold standard measurement. Therefore, a panel of measurements is recommended and including: 1. Assessment of dietary nutritional intake 2. Assessment of body composition. 3. Laboratory values 4. Scoring
  • 42. III-Laboratory evaluation 1. Visceral protein: negative acute phase reactants; albumin, prealbumin, transferrin and amino acids. 2. Lipids: chlosterol, TG and other lipids. 3. Somatic protein and nitrogen surrogates: BUN and serum creatinine. 4. Growth factors: IGF-1 and liptin. 5. Peripheral CBC, lymphocyts. 6. Others.
  • 43. III-Laboratory evaluation I-Plasma protein measurements  Serum albumin  Transferrin  Prealbumin  Amino acids
  • 44. I-Plasma protein measurements  Serum albumin  Transferrin  Prealbumin  Amino acids
  • 45. I-Plasma protein measurements Serum Albumin Clinical practice guidelines for nutrition were published by a working group for the NKF/DOQI recommended that the serum albumin concentration (obtained either predialysis or when stable) should be measured monthly.
  • 46. I-Plasma protein measurements Serum Albumin Impact of Low serum albumin level:  It is strong predictor of mortality and hospitalization; risk rises dramatically and logarithmically as levels decline below 4.0 g/dL.  It has been shown to predict coronary calcification.
  • 47.
  • 48. I-Plasma protein measurements Serum transferrin: Serum transferrin is not good indicator of nutritional status; perhaps due to fluctuations in iron stores, presence of inflammation and changes in volume status.
  • 49. I-Plasma protein measurements Prealbumin The plasma concentration of prealbumin (has a shorter half-life than albumin) provides a consistent assessment of visceral protein and can be used to assess the response to nutritional interventions begun for presumed malnutrition as it.  This protein is normally excreted and metabolized by the kidney and tends to accumulate in renal failure.
  • 50. I-Plasma protein measurements Prealbumin Value < 30 mg/dL is indicative of malnutrition in the patients on maintenance hemodialysis.
  • 51. I-Plasma protein measurements Amino acids  There is a variable plasma amino acid pattern in ESRD. In general, the levels of the essential and branched chain AA are decreased, while the nonessential AA are either within the normal range or increased.
  • 52. III-Laboratory evaluation II-Plasma cholesterol concentration  The plasma cholesterol concentration is reduced in malnourished patients with normal renal function.  Cholesterol levels are also lower in patients with ESRDs. In this setting, there is an inverse relationship between mortality and the cholesterol concentration.
  • 53. III-Laboratory evaluation III-Blood urea nitrogen Reflects the balance between urea generation and removal  Malnourished patients often show a gradual reduction in BUN and become wasted. Low levels commonly seen in dialyzed patients (well dialyzed or inadequately dialyzed) with poor nutrition. Low predialysis BUN levels have also been associated with increased mortality. It is for this reason, protein catabolic rate is monitored in dialysis patients, since this parameter can estimate protein intake in the stable patient.
  • 54. III-Laboratory evaluation IV-Creatinine production Since creatinine is produced from nonenzymatic creatine metabolism in skeletal muscle, estimating the rate of creatinine production has been used to assess lean body mass in stable patients. Estimated lean body mass was below normal in 47 and 66 % of hemodialysis and peritoneal dialysis patients, a presumed reflection of inadequate nutrition.
  • 55. III-Laboratory evaluation V- C-Reactive protein  A positive acute phase reactant protein.  It correlates negatively with visceral protein concentration.  Help to uncover potential covert inflammation especially if serum level of albumin or prealbumin is low.
  • 56. ASSESSMENT OF NUTRITIONAL STATUS No gold standard measurement. Therefore, a panel of measurements is recommended and including: 1. Assessment of dietary nutritional intake 2. Assessment of body composition. 3. Laboratory values 4. Scoring
  • 57. Subjective global assessment (SGA) • Conventional SGA is a simple method depends on the experience of clinician to make an overall evaluation of nutritional status. • Advantages: includes objective data and several manifestations of poor nutritional status. • Limitation: heavy reliance on the clinical judgment and the inability to tailor a specific nutritional therapy.
  • 58. Subjective global assessment (SGA) This is a clinical method for evaluation of nutritional status; including:- A- History and symptoms: 1- % of weight loss in the last 6 months 2- Dietary nutrient intake 3- Presence of anorexia, nausea, vomiting, diarrhea or abdominal pain 4- Functional capacity 5- Metabolic demands in the view of activity
  • 59. Subjective global assessment (SGA) B-Physical parameters focus on: • Assessment of subcutanous fat. • Assessment of muscle wasting in the temporal area, deltoid and quadriceps. • Presence of sacral or ankle odema. • Presence of ascites.
  • 60. Subjective global assessment (SGA) The SAG has good reproducibilty and correlates well with outcome in ESRD.
  • 61.
  • 62.
  • 63. Indices of malnutrition in HD patients 1. S. albumin concentration < 4.0 gm/dl. 2. Low s.prealbumin concentration (<30 mg/ dl) 3. Low b. urea & s. creatinine level in patients with residual renal function. 4. PCR < 0.8gm/Kg/day. 5. Chol. concentration<150mg/dl(3.9mmol/L). 6. Transferrin <150 mg/dl.
  • 64. Indices of malnutrition in HD patients 7. IGF-1 concentration < 300 µg/L. 8. Low predialysis serum K (and possibly phosphororus) concentration. 9. Marked reduction in anthropometric measurement 10. Continuous decline in estimated dry weight. 11. BW < 80% of ideal weight.
  • 65.
  • 66. Agenda • Definition • Factors contributing to malnutrition • Disorders of nutrient metabolism in CKD • Nutritional assessment • Nutritional therapy • Conclusion and Recommendations
  • 67. Nutritional therapy Why malnutrition should be corrected?  Many studies documented that poor nutritional status increases the morbidity and mortality CKD patients.  Specifically; low s. creatinine ,albumin concentration and % of ideal dry BW at time of initiation of maintenance dialysis are associated with increased risk of morbidity and mortality during sub sequent years of HD.
  • 68. Why malnutrition should be corrected? PEM is one of the strongest predictors of mortality and morbidity and is the third of the killing triad in CKD and HD patients 1.CV accidents 2.Infection 3.PEM Nutritional therapy
  • 69. Interventions to prevent and/or treat malnutrition in advanced kidney failure CKD patients: 1- Close supervision and nutritional counseling (especially for patients on protein- restricted diets). 2- Initiation of dialysis or kidney transplant in advanced CKD patients with apparent uremic malnutrition despite vigorous attempts to rectify it. Maintenance dialysis patients: 1- Appropriate amount of dietary protein (> 1.2 g/kg/day) and calorie (> 35 kcal/kg/day) intake. 2- Optimal dose of dialysis (urea reduction ratio > 70%). Use of biocompatible hemodialysis membranes. 3-Nutritional support in chronic dialysis patients who are unable to meet their dietary needs: a-Oral supplements. b-Tube feeds (if medically appropriate). c-Intradialytic parenteral nutritional supplements for HD patients. d-Amino acid dialysate for peritoneal dialysis patients. e-TPN
  • 70. Nutritional therapy Strategies for correction of malnutrition I. Dietary counseling, support and optimization. II. Adequate dialysis. III. Nutritional support in chronic HD patient who are unable to meet their dietary needs: 1- Oral supplementation. 2- Tube feeding(if medically appropriate). 3- IDPN supplements for HD patients. 4- AA dialysate for PD patients. 5-Continuos total parenteral nutrition(TPN)
  • 71. Nutritional therapy Other interventions 1. Correction of anemia, metabolic acidosis and SHPT. 2. Anabolic agents :insulin, growth factor, or androgenic anabolic steroid. 3. Exercise. 4. Treatment of inflammation :statin, vit E. 5. Social work. 6. Pharmacy support. 7. Transplantation.
  • 72. Nutritional therapy Dietary requirement The recommended average level of nutritional intake are listed in the following table. These recommendations are consistent with NKF ,KDOQI and EBP guidelines for nutrition for CKD patient.
  • 73. Recommended intakes of protein, energy, and minerals in kidney failure Protein Energy Phosphorus Sodium Chronic kidney disease -Stages 1-3 (GFR > 30 ml/min) -Stages 4-5 (GFR < 30 ml/min) No restriction 0.60-0.75 g/kg/day No restriction 35 kcal/kg/day 600-800 mg/day 600-800 mg/day < 2 g/day < 2 g/day End-stage renal disease -Hemodialysis - Peritoneal dialysis > 1.2 g/kg/day > 1.3 g/kg/day 35 kcal/kg/day 35 kcal/kg/day 600-800 mg/day 600-800 mg/day < 2 g/day < 2 g/day Acute renal failure -No dialysis - Dialysis 1-1.2 g/kg IBW/day 1-1.2 g/kg IBW/day 35 kcal/kg/day 35 kcal/kg/day 600-800 mg/day 600-800 mg/day < 2 g/day < 2 g/day
  • 74. 74 Recommended vitamin intake for patients receiving maintenance hemodialysis Thiamine (B1) 1.1–1.2 mg/day Riboflavin (B2) 1.1–1.3 mg/day Niacin 14–16 mg/day Pantothenic Acid 5 mg/day Vitamin B6 10 mg/day Vitamin B12 2.4 mg/day Biotin 30 mcg/day Vitamin C 75–90 mg/day Folic acid 1 mg/day Zinc 15 mg/day
  • 75. Nutritional therapy Needs for individualization Adherence to the renal diet is difficult & stressful. Prescribed diet should be individualized to help every patient in the terms of: cost, palatability, comorbidities and cultural eating habits. Too many restriction should be avoided as they may lead to poor intake. Reinforcement by all members of the family and medical stuff. Compliance should be assessed on regular basis even monthly .
  • 76. Strategies to enhance oral intake
  • 77. Adequacy of dialysis Early referral to dialysis is very crucial.  Optimal dose of dialysis(URR>70%).  Use of biocompatible HD membrane.  Keep KT/V =1-1.2  An important consensus: Adequate dialysis coupled with good nutrition is the main pillar for best quality of life. Adequate dialysis corrects uremia & anorexia which enhance nutrition.
  • 78. Peer rather than actual BW Protein and caloric recommendation should be based on the peer BW for healthy subjects of the same age, sex, height and body frame size as the patients.
  • 79. Agenda  Definition Prevalence  Factors contributing to malnutrition Nutritional assessment  Nutritional therapy  Conclusion and Recommendations
  • 80. Recommendation • Understanding and application of the nutritional principles. • Periodic assessment of nutritional status (once/ month) should be part of the routine care of CKD and dialysis patients to permit early recognition. • Providing and institution of appropriate therapy for the best improvement of nutrition status . • Renal dietitian should be a member of the medical personals.
  • 81. Take home message • PEM is underappreciated, although it largely preventable and completely curable.
  • 82.
  • 83.
  • 84.
  • 85.
  • 86.
  • 87. Recommended intakes of protein, energy, and minerals in kidney failure Protein Energy Phosphorus Sodium Chronic kidney disease -Stages 1-3 (GFR > 30 ml/min) -Stages 4-5 (GFR < 30 ml/min) No restriction 0.60-0.75 g/kg/day No restriction 35 kcal/kg/day 600-800 mg/day 600-800 mg/day < 2 g/day < 2 g/day End-stage renal disease -Hemodialysis - Peritoneal dialysis > 1.2 g/kg/day > 1.3 g/kg/day 35 kcal/kg/day 35 kcal/kg/day 600-800 mg/day 600-800 mg/day < 2 g/day < 2 g/day Acute renal failure -No dialysis - Dialysis 1-1.2 g/kg IBW/day 1-1.2 g/kg IBW/day 35 kcal/kg/day 35 kcal/kg/day 600-800 mg/day 600-800 mg/day < 2 g/day < 2 g/day
  • 88. 88 Recommended vitamin intake for patients receiving maintenance hemodialysis Thiamine (B1) 1.1–1.2 mg/day Riboflavin (B2) 1.1–1.3 mg/day Niacin 14–16 mg/day Pantothenic Acid 5 mg/day Vitamin B6 10 mg/day Vitamin B12 2.4 mg/day Biotin 30 mcg/day Vitamin C 75–90 mg/day Folic acid 1 mg/day Zinc 15 mg/day
  • 89. Recommended daily dietary intake for adult patients on maintenance hemodialysis
  • 91.
  • 92.
  • 93. A conceptual model for etiology of PEW in CKD and direct clinical implications.
  • 94. Response to reduced dietary protein and energy intake.
  • 95. Response to reduced dietary protein and energy intake.
  • 96. Response to reduced dietary protein and energy intake. • (A) Normal response. Reduced dietary protein and energy drive an increase in hunger and • a fall in REE, loss of protein preferentially from the visceral organs, and increased insulin sensitivity of muscle.The liver and kidney provide glucose, and serum albumin is maintained at a normal level. • (B) Response with PEW. During PEW, the adaptations to increase hunger and lower REE are blunted in part by an increased half-life of leptin and ghrelin and in part by inflammation and dialysis. The loss of protein occurs preferentially from muscle because of the effects of metabolic acidosis, glucocorticoids, and inflammation, leading to increased insulin resistance. Dialysis results in the loss of amino acids, stimulating muscle protein breakdown. Under the influence of inflammation and metabolic acidosis, the liver makes glutamine for deamination in the kidney, increases acute-phase reactants, and reduces serum albumin. The kidney increases glucose production from glutamine under the influence of metabolic acidosis.
  • 97. Potential causes of frailty and protein-energy wasting in elderly patients with end stage kidney disease.
  • 98.
  • 99.
  • 100.
  • 101. Clinical consequences of frailty and protein-energy wasting in elderly patients with end stage kidney disease.
  • 102. Potential preventive and therapeutic strategies for frailty and PEW in elderly ESRD patients
  • 103. Readily utilizable criteria for the clinical diagnosis of protein energy wasting in chronic kidney disease criteria
  • 104. Selected nutritional parameters for varying levels of kidney disease
  • 105. Strategies to enhance oral intake
  • 106. Potential causes of protein-energy wasting in patients with non-dialysis dependent chronic kidney disease
  • 107. Potential causes of PEM in patients with non-dialysis dependent CKD
  • 108. Potential causes of PEM in patients with non-dialysis dependent CKD
  • 109. Methods of evaluation for diagnosis of PEM in patients with non-dialysis- dependent CKD
  • 110. Schematic representation of the development of protein-energy wasting with advancing stages of CKD
  • 111.
  • 112. Selected nutritional parameters for varying levels of kidney disease (K/DOQI guidelines) Nutritional Parameters Stages 1-4 CKD Stage 5 Hemodialysis Calories (kcal/kg/d) 30 – 35 35 - 60 Protein (g/kg/d) 0.6 – 0.75 1.2 Fat (% total kcal) For patients at risk for CVD, < 10% saturated fat, 250-300 mg cholesterol/d Sodium (g/d) < 2 2 Potassium (g/d) Match to laboratory values 2 - 3 Calcium (g/d) 1.2 2 from diet and medicines Phosphorus (mg/d) Match to laboratory values 800 – 1000 Fluid (ml/d) Unrestricted with normal urine output 1000 + urine

Editor's Notes

  1. PEW is the result of multiple mechanisms inherent to CKD, including undernutrition, systemic inflammation, comorbidities, hormonal derangements, the dialysis procedure, and other consequences of uremic toxicity. PEW may cause infection, CVD, frailty, and depression, but these complications may also increase the extent of PEW.
  2. (A) Normal response. Reduced dietary protein and energy drive an increase in hunger and a fall in REE, loss of protein preferentially from the visceral organs, and increased insulin sensitivity of muscle. The liver and kidney provide glucose, and serum albumin is maintained at a normal level.
  3. (B) Response with PEW. During PEW, the adaptations to increase hunger and lower REE are blunted in part by an increased half-life of leptin and ghrelin and in part by inflammation and dialysis. The loss of protein occurs preferentially from muscle because of the effects of metabolic acidosis, glucocorticoids, and inflammation, leading to increased insulin resistance. Dialysis results in the loss of amino acids, stimulating muscle protein breakdown. Under the influence of inflammation and metabolic acidosis, the liver makes glutamine for deamination in the kidney, increases acute-phase reactants, and reduces serum albumin. The kidney increases glucose production from glutamine under the influence of metabolic acidosis.
  4. Suggested algorithm for clinical assessment and interventions aimed at assessing and treating PEW by manipulating protein intake in patients with chronic kidney disease. 1Measured with bromcresol green method. 2Head-to-head comparisons of the different supplementation methods for the treatment of PEW are not available. Individual patient characteristics and tolerance of, adherence to, and affordability of specific supplementation methods should be considered. 3Efficacy and safety because treatment of PEW is not proven. 4Ideal amount of daily protein intake in PEW is unclear. 5Directed by specific clinical scenario. The efficacy and safety of PEW treatment in patients with non-dialysis-dependent chronic kidney disease is generally unproven. DEI, daily energy intake; DPI, dietary protein intake; EAA, essential amino acid; eDPI, estimated daily protein intake; KA, keto acid; LPD, lowprotein diet; PEW, protein-energy wasting; RAAS, renin angiotensin aldosterone system.